The second largest health insurer in Massachusetts has announced that it will no longer cover specialty medications known as compounded drugs, months after a deadly nationwide meningitis outbreak was traced to a Massachusetts compounding pharmacy.
The chief medical officer at Harvard Pilgrim Health Care says the policy stems from a safety review after the meningitis outbreak traced to tainted steroids produced at New England Compounding Center in Framingham that killed 58.
Dr. Michael Sherman tells The Boston Globe that most of the insurance claims it received from patients for compounded drugs were for medications that should not be covered by a health insurer.
The coverage ends Aug. 7, but Harvard Pilgrim will consider appeals on a case by case basis.
The decision drew fire from pharmacists and patient advocates.
Topics Carriers Massachusetts
Was this article valuable?
Here are more articles you may enjoy.
P/C Statutory Results: The Highs and The Lows 
Georgia Appeals Court Reverses $345M Judgment Against Insurers in School Sex Abuse 
Prices for New Cars Have Soared. Here’s One Big Reason Why 
Indiana Church Not Owed Replacement-Cost Payment for Fire Damage 
